[Targeted biotherapies in digestive oncology: a new era in therapeutic management?].
Service d'Hépato-Gastroentérologie, CHU Robert Debré, Avenue du Général Koenig, Reims. obouche@chu-reims.fr
Olivier
O
Bouché
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001691:Biological Therapy / Q000639:trends*; D005770:Gastrointestinal Neoplasms / Q000628:therapy*; D006801:Humans
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents